SETHURAMAN NATARAJAN (Chief Scientific Officer) reported 1 transaction at ENTRADA THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 9/3/2026ACC: 0001873394-26-000005
Officer· Chief Scientific Officer
Since Oct 2021
-2.08K
Net shares
Net seller
$14.9K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
2.08K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−2.08K
Price / share
$7.14
Trade value
$14.85K
% of position
1.0%
9/2/2026
216.32K→214.24K
Total
Net shares
−2.08K
Net value
-$14.85K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/2/2026 | F · Tax Withholding | −2.08K | $7.14 | $14.85K | 1.0% | 216.32K | 214.24K |
| Total | −2.08K | -$14.85K | ||||||
Derivative Transactions0
No derivative transactions reported